Cargando…

Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis

BACKGROUND: Collecting adequate information on key epidemiological indicators is a prerequisite to informing a public health response to reduce the impact of hepatitis C virus (HCV) infection in Malaysia. Our goal was to overcome the acute data shortage typical of low/middle income countries using s...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Scott A, Mohamed, Rosmawati, Dahlui, Maznah, Naning, Herlianna, Kamarulzaman, Adeeba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229598/
https://www.ncbi.nlm.nih.gov/pubmed/25377240
http://dx.doi.org/10.1186/s12879-014-0564-6
_version_ 1782344135410188288
author McDonald, Scott A
Mohamed, Rosmawati
Dahlui, Maznah
Naning, Herlianna
Kamarulzaman, Adeeba
author_facet McDonald, Scott A
Mohamed, Rosmawati
Dahlui, Maznah
Naning, Herlianna
Kamarulzaman, Adeeba
author_sort McDonald, Scott A
collection PubMed
description BACKGROUND: Collecting adequate information on key epidemiological indicators is a prerequisite to informing a public health response to reduce the impact of hepatitis C virus (HCV) infection in Malaysia. Our goal was to overcome the acute data shortage typical of low/middle income countries using statistical modelling to estimate the national HCV prevalence and the distribution over transmission pathways as of the end of 2009. METHODS: Multi-parameter evidence synthesis methods were applied to combine all available relevant data sources - both direct and indirect - that inform the epidemiological parameters of interest. RESULTS: An estimated 454,000 (95% credible interval [CrI]: 392,000 to 535,000) HCV antibody-positive individuals were living in Malaysia in 2009; this represents 2.5% (95% CrI: 2.2-3.0%) of the population aged 15-64 years. Among males of Malay ethnicity, for 77% (95% CrI: 69-85%) the route of probable transmission was active or a previous history of injecting drugs. The corresponding proportions were smaller for male Chinese and Indian/other ethnic groups (40% and 71%, respectively). The estimated prevalence in females of all ethnicities was 1% (95% CrI: 0.6 to 1.4%); 92% (95% CrI: 88 to 95%) of infections were attributable to non-drug injecting routes of transmission. CONCLUSIONS: The prevalent number of persons living with HCV infection in Malaysia is estimated to be very high. Low/middle income countries often lack a comprehensive evidence base; however, evidence synthesis methods can assist in filling the data gaps required for the development of effective policy to address the future public health and economic burden due to HCV. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0564-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4229598
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42295982014-11-13 Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis McDonald, Scott A Mohamed, Rosmawati Dahlui, Maznah Naning, Herlianna Kamarulzaman, Adeeba BMC Infect Dis Research Article BACKGROUND: Collecting adequate information on key epidemiological indicators is a prerequisite to informing a public health response to reduce the impact of hepatitis C virus (HCV) infection in Malaysia. Our goal was to overcome the acute data shortage typical of low/middle income countries using statistical modelling to estimate the national HCV prevalence and the distribution over transmission pathways as of the end of 2009. METHODS: Multi-parameter evidence synthesis methods were applied to combine all available relevant data sources - both direct and indirect - that inform the epidemiological parameters of interest. RESULTS: An estimated 454,000 (95% credible interval [CrI]: 392,000 to 535,000) HCV antibody-positive individuals were living in Malaysia in 2009; this represents 2.5% (95% CrI: 2.2-3.0%) of the population aged 15-64 years. Among males of Malay ethnicity, for 77% (95% CrI: 69-85%) the route of probable transmission was active or a previous history of injecting drugs. The corresponding proportions were smaller for male Chinese and Indian/other ethnic groups (40% and 71%, respectively). The estimated prevalence in females of all ethnicities was 1% (95% CrI: 0.6 to 1.4%); 92% (95% CrI: 88 to 95%) of infections were attributable to non-drug injecting routes of transmission. CONCLUSIONS: The prevalent number of persons living with HCV infection in Malaysia is estimated to be very high. Low/middle income countries often lack a comprehensive evidence base; however, evidence synthesis methods can assist in filling the data gaps required for the development of effective policy to address the future public health and economic burden due to HCV. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0564-6) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-07 /pmc/articles/PMC4229598/ /pubmed/25377240 http://dx.doi.org/10.1186/s12879-014-0564-6 Text en © McDonald et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
McDonald, Scott A
Mohamed, Rosmawati
Dahlui, Maznah
Naning, Herlianna
Kamarulzaman, Adeeba
Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis
title Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis
title_full Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis
title_fullStr Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis
title_full_unstemmed Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis
title_short Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis
title_sort bridging the data gaps in the epidemiology of hepatitis c virus infection in malaysia using multi-parameter evidence synthesis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229598/
https://www.ncbi.nlm.nih.gov/pubmed/25377240
http://dx.doi.org/10.1186/s12879-014-0564-6
work_keys_str_mv AT mcdonaldscotta bridgingthedatagapsintheepidemiologyofhepatitiscvirusinfectioninmalaysiausingmultiparameterevidencesynthesis
AT mohamedrosmawati bridgingthedatagapsintheepidemiologyofhepatitiscvirusinfectioninmalaysiausingmultiparameterevidencesynthesis
AT dahluimaznah bridgingthedatagapsintheepidemiologyofhepatitiscvirusinfectioninmalaysiausingmultiparameterevidencesynthesis
AT naningherlianna bridgingthedatagapsintheepidemiologyofhepatitiscvirusinfectioninmalaysiausingmultiparameterevidencesynthesis
AT kamarulzamanadeeba bridgingthedatagapsintheepidemiologyofhepatitiscvirusinfectioninmalaysiausingmultiparameterevidencesynthesis